{
 "drug": "Travoprost Ophthalmic Solution",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/07/2026",
 "dayN": 49,
 "cat": "Ophthalmology",
 "companies": [
  "Mylan Pharmaceuticals Inc., a Viatris Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/07/2026",
   "update_type": "New",
   "initial_posting_date": "07/07/2026",
   "package_ndc": "0378-9651-50",
   "generic_name": "Travoprost Ophthalmic Solution",
   "contact_info": "877-446-3679",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA205050"
    ],
    "brand_name": [
     "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
    ],
    "generic_name": [
     "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-9651"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "OPHTHALMIC"
    ],
    "substance_name": [
     "TRAVOPROST"
    ],
    "rxcui": [
     "284008"
    ],
    "spl_id": [
     "d78c5705-68ac-4363-b9ae-5facc60e2b79"
    ],
    "spl_set_id": [
     "00dc284f-fd96-423b-bb8f-b90ee13439bf"
    ],
    "package_ndc": [
     "0378-9651-32",
     "0378-9651-50"
    ],
    "nui": [
     "N0000175454",
     "M0017805"
    ],
    "pharm_class_epc": [
     "Prostaglandin Analog [EPC]"
    ],
    "pharm_class_cs": [
     "Prostaglandins [CS]"
    ],
    "unii": [
     "WJ68R08KX9"
    ]
   },
   "update_date": "07/07/2026",
   "therapeutic_category": [
    "Ophthalmology"
   ],
   "dosage_form": "Ophthalmic Solution",
   "presentation": "Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/07/2026",
   "update_type": "New",
   "initial_posting_date": "07/07/2026",
   "package_ndc": "0378-9651-32",
   "generic_name": "Travoprost Ophthalmic Solution",
   "contact_info": "877-446-3679",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA205050"
    ],
    "brand_name": [
     "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
    ],
    "generic_name": [
     "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
    ],
    "manufacturer_name": [
     "Mylan Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "0378-9651"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "OPHTHALMIC"
    ],
    "substance_name": [
     "TRAVOPROST"
    ],
    "rxcui": [
     "284008"
    ],
    "spl_id": [
     "d78c5705-68ac-4363-b9ae-5facc60e2b79"
    ],
    "spl_set_id": [
     "00dc284f-fd96-423b-bb8f-b90ee13439bf"
    ],
    "package_ndc": [
     "0378-9651-32",
     "0378-9651-50"
    ],
    "nui": [
     "N0000175454",
     "M0017805"
    ],
    "pharm_class_epc": [
     "Prostaglandin Analog [EPC]"
    ],
    "pharm_class_cs": [
     "Prostaglandins [CS]"
    ],
    "unii": [
     "WJ68R08KX9"
    ]
   },
   "update_date": "07/07/2026",
   "therapeutic_category": [
    "Ophthalmology"
   ],
   "dosage_form": "Ophthalmic Solution",
   "presentation": "Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)",
   "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
   "status": "To Be Discontinued"
  }
 ]
}